Oncternal Therapeutics, Inc. (ONCT)

Oncternal Therapeutics Market Cap

Oncternal Therapeutics has a market cap or net worth of $26.22 million as of April 19, 2024. Its market cap has increased by 61.87% in one year.

• Market Cap: 26.22M
• Enterprise Value: -7.71M
• 1-Year Change: 61.87%
• Ranking: #4877
• Category: Nano-Cap
• Stock Price: $8.86

Market Cap Chart

Since February 3, 2004, Oncternal Therapeutics's market cap has decreased from $317.20M to $26.22M, a decrease of -91.73%. That is a compound annual growth rate of -11.60%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	25.50M	-3.77%
Apr 17, 2024	26.50M	3.11%
Apr 16, 2024	25.70M	-1.15%
Apr 15, 2024	26.00M	-6.47%
Apr 12, 2024	27.80M	4.91%
Apr 11, 2024	26.50M	3.11%
Apr 10, 2024	25.70M	0.78%
Apr 9, 2024	25.50M	-4.14%
Apr 8, 2024	26.60M	3.91%
Apr 5, 2024	25.60M	-1.54%
Apr 4, 2024	26.00M	-2.26%
Apr 3, 2024	26.60M	-2.92%
Apr 2, 2024	27.40M	-0.36%
Apr 1, 2024	27.50M	3.38%
Mar 28, 2024	26.60M	9.47%
Mar 27, 2024	24.30M	2.10%
Mar 26, 2024	23.80M	-2.06%
Mar 25, 2024	24.30M	-
Mar 22, 2024	24.30M	2.97%
Mar 21, 2024	23.60M	-4.45%
Mar 20, 2024	24.70M	6.01%
Mar 19, 2024	23.30M	0.87%
Mar 18, 2024	23.10M	-2.53%
Mar 15, 2024	23.70M	2.60%
Mar 14, 2024	23.10M	-13.81%

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
BioVie	26.80M
Forte Biosciences	26.70M
NKGen Biotech	26.49M
Sol-Gel Technologies	26.35M
Aileron Therapeutics	26.14M
Unity Biotechnology	25.51M
Lipocine	25.30M
Qilian International Holding Group	24.99M